These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25441457)

  • 41. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
    Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
    Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.
    Lennard L; Lilleyman JS; Van Loon J; Weinshilboum RM
    Lancet; 1990 Jul; 336(8709):225-9. PubMed ID: 1973780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity.
    Serpe L; Calvo PL; Muntoni E; D'Antico S; Giaccone M; Avagnina A; Baldi M; Barbera C; Curti F; Pera A; Eandi M; Zara GP; Canaparo R
    Pharmacogenomics; 2009 Nov; 10(11):1753-65. PubMed ID: 19891552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Al-Modhwahi I; Andersen MK; Behrendtz M; Forestier E; Hasle H; Heyman M; Kristinsson J; Nersting J; Nygaard R; Svendsen AL; Vettenranta K; Weinshilboum R;
    Blood; 2009 Jun; 113(24):6077-84. PubMed ID: 19224761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients.
    Sabirova Z; Mahnoor S; Lasfar D; Gagné V; Théorêt Y; Leclerc JM; Laverdière C; Sinnett D; Tran TH; Krajinovic M
    Pharmacogenet Genomics; 2024 Jul; 34(5):170-173. PubMed ID: 38682355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.
    McBride KL; Gilchrist GS; Smithson WA; Weinshilboum RM; Szumlanski CL
    J Pediatr Hematol Oncol; 2000; 22(5):441-5. PubMed ID: 11037857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TPMT genetic variations in populations of the Russian Federation.
    Samochatova EV; Chupova NV; Rudneva A; Makarova O; Nasedkina TV; Fedorova OE; Glotov AS; Kozhekbaeva Zh; Maiorova OA; Roumyantsev AG; Krynetski EY; Krynetskaia NF; Evans WE; Ribeiro RC
    Pediatr Blood Cancer; 2009 Feb; 52(2):203-8. PubMed ID: 19034904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.
    Bo J; Schrøder H; Kristinsson J; Madsen B; Szumlanski C; Weinshilboum R; Andersen JB; Schmiegelow K
    Cancer; 1999 Sep; 86(6):1080-6. PubMed ID: 10491537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
    Asadov C; Aliyeva G; Mustafayeva K
    Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Möricke A; Buchmann S; Zimmermann M; Igel S; Schmiegelow K; Flotho C; Hartmann H; Illsinger S; Sauerbrey A; Junk SV; Schütte P; Hinze L; Lauten M; Modlich S; Kolb R; Rossig C; Schwabe G; Gnekow AK; Fleischhack G; Schlegel PG; Schünemann HJ; Kratz CP; Cario G; Schrappe M; Schwab M
    Leukemia; 2021 Sep; 35(9):2650-2657. PubMed ID: 33714975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.
    McLeod HL; Relling MV; Liu Q; Pui CH; Evans WE
    Blood; 1995 Apr; 85(7):1897-902. PubMed ID: 7703493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions.
    Lennard L
    Ther Drug Monit; 1998 Oct; 20(5):527-31. PubMed ID: 9780130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thiopurine methyltransferase: a review and a clinical pilot study.
    Keuzenkamp-Jansen CW; Leegwater PA; De Abreu RA; Lambooy MA; Bokkerink JP; Trijbels JM
    J Chromatogr B Biomed Appl; 1996 Mar; 678(1):15-22. PubMed ID: 8861653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
    Vora A; Mitchell CD; Lennard L; Eden TO; Kinsey SE; Lilleyman J; Richards SM; ;
    Lancet; 2006 Oct; 368(9544):1339-48. PubMed ID: 17046466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.
    McLeod HL; Pritchard SC; Githang'a J; Indalo A; Ameyaw MM; Powrie RH; Booth L; Collie-Duguid ES
    Pharmacogenetics; 1999 Dec; 9(6):773-6. PubMed ID: 10634140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency.
    Murphy LA; Atherton DJ
    Pediatr Dermatol; 2003; 20(6):531-4. PubMed ID: 14651577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.
    Salavaggione OE; Wang L; Wiepert M; Yee VC; Weinshilboum RM
    Pharmacogenet Genomics; 2005 Nov; 15(11):801-15. PubMed ID: 16220112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.
    Lennard L; Gibson BE; Nicole T; Lilleyman JS
    Arch Dis Child; 1993 Nov; 69(5):577-9. PubMed ID: 8257179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency.
    Andersen JB; Szumlanski C; Weinshilboum RM; Schmiegelow K
    Acta Paediatr; 1998 Jan; 87(1):108-11. PubMed ID: 9510461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age.
    Ganiere-Monteil C; Medard Y; Lejus C; Bruneau B; Pineau A; Fenneteau O; Bourin M; Jacqz-Aigrain E
    Eur J Clin Pharmacol; 2004 Apr; 60(2):89-96. PubMed ID: 15022030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.